Works matching IS 09291903 AND DT 2006 AND VI 13 AND IP 2

Results: 11

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 125, doi. 10.1038/sj.cgt.7700865

By:

Tao, Z.;
Connor, R. J.;
Ashoori, F.;
Dinney, C. P. N.;
Munsell, M.;
Philopena, J. A.;
Benedict, W. F.

Publication type:

Article

Targeted gene therapy for breast cancer with truncated Bid.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 141, doi. 10.1038/sj.cgt.7700867

By:

Kazhdan, I.;
Long, L.;
Montellano, R.;
Cavazos, D. A.;
Marciniak, R. A.

Publication type:

Article

A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 159, doi. 10.1038/sj.cgt.7700868

By:

Ren, X. -W.;
Liang, M.;
Meng, X.;
Ye, X.;
Ma, H.;
Zhao, Y.;
Guo, J.;
Cai, N.;
Chen, H. -Z.;
Ye, S .-L.;
Hu, F.

Publication type:

Article

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 169, doi. 10.1038/sj.cgt.7700870

By:

Atencio, I. A.;
Grace, M.;
Bordens, R.;
Fritz, M.;
Horowitz, J. A.;
Hutchins, B.;
Indelicato, S.;
Jacobs, S.;
Kolz, K.;
Maneval, D.;
Musco, M. L.;
Shinoda, J.;
Venook, A.;
Wen, S.;
Warren, R.

Publication type:

Article

Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 131, doi. 10.1038/sj.cgt.7700871

By:

Mizuno, T.;
Nagao, M.;
Yamada, Y.;
Narikiyo, M.;
Ueno, M.;
Miyagishi, M.;
Taira, K.;
Nakajima, Y.

Publication type:

Article

Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 194, doi. 10.1038/sj.cgt.7700873

By:

Yamamoto, M.;
Nishimoto, N.;
Davydova, J.;
Kishimoto, T.;
Curiel, D. T.

Publication type:

Article

Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 203, doi. 10.1038/sj.cgt.7700874

By:

Kaliberov, S. A.;
Chiz, S.;
Kaliberova, L. N.;
Krendelchtchikova, V.;
Della Manna, D.;
Zhou, T.;
Buchsbaum, D. J.

Publication type:

Article

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 150, doi. 10.1038/sj.cgt.7700882

By:

Gommans, W. M.;
van Eert, S. J.;
McLaughlin, P. M. J.;
Harmsen, M. C.;
Yamamoto, M.;
Curiel, D. T.;
Haisma, H. J.;
Rots, M. G.

Publication type:

Article

Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 215, doi. 10.1038/sj.cgt.7700883

By:

Li, L. H.;
Biagi, E.;
Allen, C.;
Shivakumar, R.;
Weiss, J. M.;
Feller, S.;
Yvon, E.;
Fratantoni, J. C.;
Liu, L. N.

Publication type:

Article

Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 182, doi. 10.1038/sj.cgt.7700888

By:

Courrèges, M. C.;
Benencia, F.;
Conejo-García, J. R.;
Zhang, L.;
Coukos, G.

Publication type:

Article

The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 2, p. 115, doi. 10.1038/sj.cgt.7700896

By:

Baron, V.;
Adamson, E. D.;
Calogero, A.;
Ragona, G.;
Mercola, D.

Publication type:

Article